WebSep 8, 2024 · Rachel’s career is notable for, among other achievements, her overall supervision of the early and late-stage clinical development of ipilimumab (Yervoy ®) at … WebPeople named Rachael Humphrey. Find your friends on Facebook. Log in or sign up for Facebook to connect with friends, family and people you know. Log In. or. Sign Up. Rachel Humphrey. See Photos. Rachel Humphrey.
Rachel W. Humphrey, MD - President and Founding CEO
WebSep 29, 2024 · Contacts. For Investor Inquiries: Joseph Farmer, Chief Operating Officer Xilio Therapeutics [email protected] (617) 430-4762 For Media Inquiries: Rachel Eides W2O … WebView the profiles of people named Rachel Humphrey. Join Facebook to connect with Rachel Humphrey and others you may know. Facebook gives people the power... night mode option in app
Sporos Bioventures Appoints Dr. Rachel Humphrey to Board of …
WebSep 8, 2024 · Dr. Humphrey brings more than 20 years of experience as a leader in oncology drug development. CAMBRIDGE, Mass. and NEW YORK, Sept. 08, 2024 (GLOBE … WebSep 29, 2024 · Previously, she held numerous senior leadership roles in cancer drug development, including Vice President, Head of Immuno-Oncology at Eli Lilly and Company, SVP and Head of Immuno-Oncology at AstraZeneca, Executive VP and Chief Medical Officer at Mirati Therapeutics, and VP, Clinical Development at Bristol-Myers Squibb (BMS). Dr. … WebRachel Humphrey has over 25 years of experience in clinical drug development, ... at BMS, the PD-L1 inhibiting immunotherapy Imfinzi® (durvalumab) at AstraZeneca, and the … night mode screen on kindle fire